As of Mar 29
| -0.03 / -1.72%|
The 1 analysts offering 12-month price forecasts for ContraVir Pharmaceuticals Inc have a median target of 4.00, with a high estimate of 4.00 and a low estimate of 4.00. The median estimate represents a +133.92% increase from the last price of 1.71.
The current consensus among 1 polled investment analysts is to Buy stock in ContraVir Pharmaceuticals Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.